You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

idiopathic Castleman's disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ProducingNovel Symptom Burden Scale for People Living With

Not yet recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Research questions
  • (no location specified)
Aug 17, 2023

Castleman Disease, Castleman's Disease, Multicentric Trial in Little Rock, La Jolla, Philadelphia (Sirolimus)

Recruiting
  • Castleman Disease
  • Castleman's Disease, Multicentric
  • Little Rock, Arkansas
  • +3 more
Jan 6, 2023

Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
  • +2 more
  • Beijing, China
  • +2 more
Apr 26, 2022

Idiopathic Multicentric Castleman's Disease Trial in Beijing (Zanubrutinib)

Recruiting
  • Idiopathic Multicentric Castleman's Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Feb 5, 2021

Idiopathic Multicentric Castleman's Disease Trial in Lansing (Siltuximab)

Terminated
  • Idiopathic Multicentric Castleman's Disease
  • Lansing, Michigan
    Edward W. Sparrow Hospital
Apr 15, 2021

Castleman Disease, Castleman's Disease, Giant Lymph Node Hyperplasia Trial in Worldwide

Recruiting
  • Castleman Disease
  • +8 more
    • Philadelphia, Pennsylvania
    • +9 more
    Dec 5, 2022

    KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by

    Not yet recruiting
    • KSHV Inflammatory Cytokine Syndrome (KICS)
    • Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 2, 2023

    Unicentric Form of Castleman Disease - Surgery Therapy Benefit

    Completed
    • Castleman Disease
    • +2 more
    • surgery type/exstirpation/debulking
    • (no location specified)
    Jun 28, 2022

    Castleman's Disease (CD), Langerhans Cell Histiocytosis (LCH), Non-Langerhans-Cell Histiocytosis Trial in Cleveland (Genetic

    Recruiting
    • Castleman's Disease (CD)
    • +2 more
    • Genetic testing
    • Cleveland, Ohio
      Cleveland Clinic, Case Comprehensive Cancer Center
    Jun 21, 2022

    Multicentric Castleman Disease Trial in Lilongwe (Rituximab, Etoposide)

    Recruiting
    • Multicentric Castleman Disease
    • Lilongwe, Malawi
      UNC Project, Kamuzu Central Hospital
    May 2, 2022

    Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

    Active, not recruiting
    • Lymphoproliferative Disorder
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    s From HIV Infection, KSHV Infection, Viral-Related

    Recruiting
    • HIV
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Collecting Blood and Tissue Sample Donations for Research for

      Not yet recruiting
      • Anal Carcinoma
      • +11 more
      • Biospecimen Collection
      • (no location specified)
      Dec 21, 2022

      Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin

      Not yet recruiting
      • Juvenile Idiopathic Arthritis
      • fibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)
      • (no location specified)
      Aug 29, 2023

      Inflammatory Myopathy, Cardiac Disease Trial

      Not yet recruiting
      • Inflammatory Myopathy
      • Cardiac Disease
        • (no location specified)
        Aug 4, 2023

        Idiopathic Parkinson's Progression and Dopamine Transporter

        Completed
        • Parkinson Disease
        • Ioflupane I 123
        • Lexington, Kentucky
          University of Kentucky Department of Neurology
        Nov 16, 2022

        Parkinson Disease, Treatment Adherence Trial in Ankara (Levodopa)

        Enrolling by invitation
        • Parkinson Disease
        • Treatment Adherence
        • Ankara, Turkey
          Ankara Atatürk Sanatorium Training and Research Hospital
        Oct 30, 2023

        Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement Trial in El Paso (Vixarelimab, Placebo)

        Recruiting
        • Idiopathic Pulmonary Fibrosis
        • Systemic Sclerosis With Lung Involvement
        • El Paso, Texas
          El Paso Pulmonary Association Elligo PPDS
        Mar 14, 2023

        Psychiatric Co-morbidities and Socio-demographic Characteristics

        Recruiting
        • Idiopathic Hypersomnia
        • +2 more
        • respond to questionnaires by telephone
        • Toulouse, France
          Chu Toulouse
        Mar 9, 2023

        A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

        Recruiting
        • Multiple Myeloma
        • +11 more
        • No intervention
        • Beijing, China
          Peking University First Hospital
        Apr 21, 2022

        Idiopathic Parkinson's Disease Trial in Shanghai (hAESCs)

        Not yet recruiting
        • Idiopathic Parkinson's Disease
        • hAESCs
        • Shanghai, Shanghai, China
          Shanghai East Hospital
        Jan 28, 2023

        Parkinson Disease Trial (NeuraLight)

        Not yet recruiting
        • Parkinson Disease
        • NeuraLight
        • (no location specified)
        May 17, 2023

        Parkinson Disease Trial (NeuraLight)

        Not yet recruiting
        • Parkinson Disease
        • NeuraLight
        • (no location specified)
        Mar 29, 2023

        Fabry Disease in Portuguese Idiopathic Cardiomyopathies

        Recruiting
        • Fabry Disease
        • Alfa-galactosidase activity and genetic testing for Fabry diagnosis
        • Porto, Portugal
          Centro Hospitalar Universitário São João
        Jan 12, 2023

        Nephrotic Syndrome, Proteinuria, Autoimmune Disease Trial run by the NIDDK (Rituximab Infusion, Oral Cyclosporine)

        Recruiting
        • Nephrotic Syndrome
        • +4 more
        • Rituximab Infusion
        • Oral Cyclosporine
        • Bethesda, Maryland
        • +1 more
        Jan 25, 2023